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Chapter 1 
 
 
1.1 Apexification with Calcium Hydroxide 
 
Traumatic injury or a depth caries penetration, during the developing 
of dentition, could lead to a premature pulp necrosis of immature 
permanent tooth. Dental injuries are most common in young patients 
(8-14 years), when children are most active. In these cases 
endodontics treatment aimed to keep the dentition in physiologically 
functional state for the maintenance of oral and systemic health. Teeth 
with immature root development present challenges in cleaning, 
shaping and obturation of large canals with open apices (1-3). In these 
cases conventional root canal treatment can be overcome using 
Calcium Hydroxide Ca(OH)2 apexification approach (4) or Mineral 
Trioxide Aggregate (MTA) apical plug technique (5). In both clinical 
approaches the risk of future root fracture and tooth mobility, due to a 
poor root-crown ratio, still remains.  
Apexification is defined as ‘‘a method of inducing a calcified barrier 
in a root with an open apex or the continued apical development of an 
incompletely formed root in teeth with necrotic pulp”. Teeth treated 
with this material require the placement of long-term calcium 
hydroxide in the root canal to induce formation of an apical hard 
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tissue barrier. The formation of the apical barrier is necessary to allow 
the filling of the root canal system without risk of overfilling 
The high pH and antimicrobial properties (6) of Ca(OH)2 combined 
with the permeability of dentin (7) guided to a common and well 
established use of  calcium hydroxide in dentistry.  
Hermann introduced the use of calcium hydroxide in 1920 (8); it was 
often applied within the root canal system as intracanal medicament 
and in apexification procedure. In 1964 Kaiser (9) proposed the use of 
calcium hydroxide mixed with camphorate parachlorophenol to 
induce the formation of calcified barrier across the apex. 
Frank (5), who emphasized the importance of reducing contamination 
within the root canal by instrumentation, medication and dressing the 
canal space temporarily with a reasonable paste seal, popularized this 
procedure. 
The use of calcium hydroxide mixed with saline solution (10), sterile 
water (11), or distilled water (12) has been investigate with good 
clinical success; the mechanism of action of calcium hydroxide in 
induction of an apical barrier remain controversial; two different 
aspects could play an important role in osteogenetic potential of 
calcium hydroxide: mineralized and antibacterial actions. Ca(OH)2 
induced a multi-layered necrosis (13) with subjacent mineralization; 
the necrosis generates a low grade of irritation of underlying tissue 
sufficient to produce a matrix that mineralized. Calcium was attracted 
to this area and the mineralization of newly formed collagenous 
matrix is initiated from the calcified foci. The apical barrier formation 
is more successful in the absence of microorganism, the release of 
hydroxyl ions cause the damage to bacterial cytoplasmic membrane, 
protein denaturation and damage to bacterial DNA (14-19). The hard 
tissue barrier formed at the end of the root has been histologically 
described as follow: an outer layer composed of a dense acellular 
cementum-like tissue and a more central mix of irregular dense fibro-
collagenous connective tissue containing foreign material highly 
mineralized (20).  By using repeated Ca(OH)2 dressings, during a 3 to 
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6 months period, it demonstrated that it was possible not only to 
induce healing of the apical lesion but also to induce closure of the 
root apex with calcified tissue (apexification).  
When Ca(OH)2 is used in apexification procedure, the therapy could 
extend from months to years before achieve the desired effect (21,22). 
In a review Sheehy and Robert reported an average duration for apical 
barrier formation ranging from 5 to 20 mouths (21); the high 
variability could be due to: presence or absence of periradicular 
lesion, and /or stage of  root development and consequent apical width 
(23). Immature teeth treated with Ca(OH)2 showed an high failure rate 
because of an unusual incidence of root fracture. This might be the 
direct consequence of changes in the physical properties of dentin due 
to the use of Ca(OH)2 medicament (1, 24, 25). Cvek (1), investigated 
885 luxated non-vital teeth over a period ranging from 3 to 54 months, 
reported that 168 teeth suffered a cervical root fracture within the 
follow-up period, ranged from 3.5 to 5 years. Each failed teeth showed 
a cervical resorptive defect near the fracture; this may be a result of a 
change in the organic matrix (2, 25). Calcium hydroxide dissolves 
pulp tissue because of denaturation and hydrolysis of dentin proteins, 
furthermore the high pH reduce the organic support of the dentin 
matrix; both effects result in a loose of connection between collagen 
fibrils and hydroxyapatite crystals, that could negatively influence 
mechanical properties of dentin (2, 25, 26, 27). The weakening of the 
root structure in term of on micro-tensile fracture strength of dentine 
tissue after prolonged used of calcium hydroxide, was supported by in 
vitro studies too (28, 29).  
Outcome assessment of calcium hydroxide in apexification treatments, 
showed a success rates ranged from 79% to 100% (1,30-34). Based on 
a meta-analysis and systematic review the rate of clinical success and 
apical barrier formation mineral trioxide aggregate and calcium 
hydroxide as material used for the endodontic management of 
immature teeth had no perceivable discrepancy (35). 
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Chapter 2 
 
Despite the high success rate of long term calcium hydroxide 
apexification (mid 90%), the disadvantage of this technique (1), 
multiple appointment during an extended period of time, susceptibility 
to root fracture, risk of coronal micro-leakage during the therapy; lead 
to alternative treatment that might be offer a more predictable and 
better long-term prognosis for necrotic teeth with incomplete root 
development.   
Artificial apical barriers with a variety of materials have been 
suggested as an alternative to traditional Ca(OH)2 apexification (2-7). 
In 1999 Torabinejad and Chivian proposed the use of a new material, 
Mineral Trioxide Aggregate (MTA), as artificial apical barrier for the 
treatment of immature necrotic teeth (8). 
 
2.1 Mineral Trioxide Aggregate: Chemical composition and setting 
reaction  
 
Mineral trioxide aggregate (MTA) was developed at Loma Linda 
University, in the 1990s, as a root-end filling material. It was used 
primarily to seal lateral root perforations (8,9) and as root-end filling 
material (10-13). In 1998 Mineral trioxide aggregate (MTA) received 
acceptance by the US Federal Drug Administration and became 
commercially available as ProRoot MTA (Tulsa Dental Products, 
Tulsa, OK, USA).  
The literature widely documented the physical, chemical and 
biological characteristics of MTA; it’s consist in a powder contains 
50-75% calcium oxide (CaO) and 15-25% silicon dioxide (SiO2). 
13 
 
These two components together comprise 70-95% of the cement (11, 
14, 19, 20, 21).  
Scanning electron microscope (SEM) of polished sections of un-
hydrated MTA embedded in resin, show distinctive cement grains and 
bismuth oxide particles, which are separated from one another. The 
mean value of the prisms was 87% calcium and 2.47% silica, the 
remainder being oxygen. In areas of amorphous structure, there 
seemed to be 33% calcium, 49% phosphate, 2% carbon, 3% chloride, 
and 6% silica. 
The elemental composition of MTA as shown by energy dispersive 
spectroscopy (EDS) indicates the presence of calcium, silicon and 
oxygen with minor peaks for aluminium, potassium, magnesium and 
bismuth. The phases present in un-hydrated MTA, determined by X-
ray diffraction analysis, exhibits peaks for tricalcium silicate, 
dicalcium silicate and bismuth oxide. Each phase has a particular 
pattern that can be subsequently searched and matched with data 
derived from the International Centre of Diffraction. MTA contains 
other phases such as dicalcium silicate and tricalcium aluminate in 
minimal quantities. In the first publication on MTA composition, 
calcium phosphate was the main constituent of MTA (9). Further 
analysis demonstrated that the former appeared as discrete crystals 
and the latter as an amorphous structure with no apparent crystal 
growth but a granular appearance.  
When these raw materials are blended, they produce tricalcium 
silicate, dicalcium silicate, tricalcium aluminate, and tetracalcium 
aluminoferrite. Various methods have been used to examine MTA 
composition including energy dispersive analysis with x-ray (EDAX), 
inductively coupled plasma optical emission spectroscopy (ICP-OES), 
x-ray diffraction analyses (XRD), x-ray fluorescence spectrometry 
(XRF), energy x-ray spectrometry, and energy dispersive 
spectroscopy (9–18).  
Mineral Trioxide Aggregate is available in two commercial form grey 
MTA (GMTA), the oldest formula, and white MTA (WMTA), the 
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newest formula. The difference between the grey and the white 
materials is the presence of iron in the grey material, which makes up 
the phase tetracalcium alumina-ferrite. This phase is absent in white 
MTA.  
Mixing MTA powder with sterile water in a 3:1 powder-to-liquid ratio 
(22) we obtain a colloidal gel that solidifies into a hard structure. 
During the initial stages of the reaction of MTA after hydratation, 
calcium silicate hydrate is formed, coating the cement particles and 
preventing further reactions. Tricalcium aluminate dissolves and 
reacts with the calcium and sulfate ions present in the liquid phase to 
produce ettringite, which also precipitates on the cement particle 
surface. The initial phase is followed by a dormant period, wherein the 
hydrate coating on the cement grains prevents further hydration. The 
dormant period lasts for 1-2 hours, which is a period of relative 
inactivity and the cement is plastic and workable. Following the 
completion of the dormant period, setting of the cement proceeds to 
the acceleration stage, where the hydration process accelerates again. 
Sulfate ions are depleted and monosulfate forms from ettringite. 
Crystalline calcium hydroxide also precipitates from the liquid phase 
(20). 
The hydration reaction takes several years to complete, although the 
cement mass would have achieved the final hardening and maximum 
physical and mechanical properties by 28 days. 
If MTA is left exposed to the environment, the calcium hydroxide 
reacts with the atmospheric carbon dioxide resulting in the deposition 
of calcium carbonate on the cement surface. These deposits are 
commonly mistaken as being an integral part of the cement 
microstructure. When in contact with tissue fluids and synthetic tissue 
fluids, which contain phosphate ions, the calcium hydroxide produced, 
as a by-product of MTA hydration, reacts to form calcium phosphate 
and is deposited on the cement surface. Calcium phosphate is crystal 
on the material surface has been reported to be the reason for the 
bioactivity shown by MTA. 
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One of the characteristics of a bioactive material is its ability to form 
an apatite-like layer on its surface when it comes in contact with 
physiologic fluids (23, 24).Apatite formation is a common 
characteristic of calcium silicate–containing biomaterials (25,26). 
Hydroxyapatite can release calcium and phosphorus continuously, a 
process required for bone metabolism (27). In addition, this 
phenomenon increases the sealing ability of MTA and promotes the 
regeneration and remineralization of hard tissues. On the basis of 
these results, Sarkar et al. (27) suggested that the biocompatibility, 
sealing-ability, and dentinogenic activity of MTA result from the 
physiochemical reactions between MTA and tissue fluids during the 
formation of HA. 
Several liquids have been used to hydrate MTA powder. The mean 
setting time of MTA is 165± 5 minutes, which is longer than 
amalgam, Super EBA, and intermediate restorative material (IRM) 
(9).  
 
3CaO.Al2O3 + CaSO4 tricalcium aluminate                                          
ettingite 
3CaO.SiO2 tricalcium silicate                                                   calcium 
silicate hydrate 
2CaO.2SiO2 dicalcium silicate                                                  and 
calcium hydroxide 
 
 
 
                                                                                                Calcium 
carbonate           cristal of calcium phospate                        
                                                                                                                                         
 
H2O 
CO2 Tissue 
PO4 
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2.2 Biocompatibility and bioactivity of Mineral Trioxide Aggregate 
 
The MTA cement reflect a current requirement to have materials for 
endodontic therapy that are able to stimulate the healing process of 
periapical tissues, instead of merely biocompatible or inert materials. 
In the past decade, the two major characteristics that justify the 
successful use of MTA in endodontics were the excellent seal ability 
and biocompatibility. In case of necrotic teeth with immature root 
development, MTA has been advocated as an apexification material 
because it permits an adequate seal of the canal preventing bacterial 
leakage, and a poor inflammatory reaction in periodontal tissue.  
Nowadays, it’s well-documented the favourable biologic response 
stimulated by MTA in human periapical tissue; cell from periradicular 
healing tissue migrate to the apex and differentiate in cells capable of 
secreting a cementum, osteocementum or osteodentin organic matrix 
under the influence of specific cellular signals (28). Bone and 
periodontal healing/regeneration is a complex event that involves the 
different stages (30), in which the migration and invasion of 
multipotent mesenchymal stem cells are required (31).  
When MTA has been placed in direct contact with human tissues, the 
following reaction have been observed: 
 Releases calcium ions and facilitates cell attachment and 
proliferation. The ability of MTA to moderate the migration of cells 
should probably be considered to be an important stage in the 
induction of tissue repair. Apical barrier formation can occur even in 
the presence of gaps between the MTA plug and the root canal walls. 
This observation was probably related to the ability of MTA to 
enhance cell migration of human bone marrow stem cells (29).  
Currently human PDL cells were used to simulate the root-end 
environment; these cells are responsible for the formation and 
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maintenance of periodontal ligament fiber attachments as well as 
repair, remodelling, and regeneration of the adjacent alveolar bone 
and cementum. In a human PDL cell culture study, cell attachment to 
MTA was observed; PDL fibroblasts showed proliferation on MTA 
and survival.  
 
 Creates antibacterial environment by its alkaline pH. The bioactivity 
of MTA has been attribute to its ability to produce hydroxyapatite 
(Ca5(PO4)3(OH)) in presence of phosphate buffered saline. The 
hydroxyapatite is a crystal presents in form of calcium carbonate, 
calcium phosphate and calcium floruro. Initially an amorphous 
calcium phosphate phase is formed, which acts as a precursor to the 
secondary phase during which carbonated apatite is formed. 
Carbonated apatite is also known as biologic apatite and represents the 
mineral phase of hard tissue (bone, dentin, and cementum) (32, 33). 
The bioactivity of MTA could be attributed to its capacity to form 
carbonated apatite, which is important in formation and maintenance 
of the bone tissue biomaterial interface. The apatite formed by the 
cement-Phosfate Buffered Saline (PBF) system was deposited within 
collagen fibrils, promoting controlled mineral nucleation on dentin as 
reported by Reyes-Carmona et al (34). The possible biologic and 
clinical significance of their findings includes the following:  
           (1) the interaction of MTA and Portland cement  with dentin in a 
phosphate-containing fluid promotes a biomineralization process,  
           (2) This process could be significant in minimizing  leakage,  
           (3) The formation of the interfacial layer and the intratubular 
mineralization process could     influence the push-out bond strength, 
and  
           (4) The formation of carbonated apatite precipitates could be 
responsible for the ability of the cements to stimulate repair and 
dentinogenesis or cementogenesis.  
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 Modulates cytokine production. Basing on In vitro and in vivo animal 
study, MTA seems to play a role on the production of signalling 
molecules. Macrophages produce different types of cytokines, 
signalling molecules and inflammatory products. Up regulation of 
various types of cytokines and biologic markers has been reported in 
the presence of MTA in several cell culture studies when compared 
with control or other tested materials. These cytokines and biologic 
markers include interleukin (IL)-1a (36, 37), IL-1 b (36-38), IL-2(39), 
IL-4(39), IL-6(36, 38, 40), IL-8 (41), IL-10 (39), IL-18 (36), 
osteocalcin (36, 39, 42-44), alkaline phosphatase (42, 44, 45), bone 
sialoprotein (44), osteopontin (44), and BMP-2 (45). 
 Encourages differentiation and migration of hard tissue producing 
cells. MTA can induce osteoblastic/cementoblastic differentiation of 
human periodontal ligament cells, which express calcium sensing 
receptors (CaSR) and bone morphogenetic protein-2 (BMP-2) 
receptors that are potentially involved in osteogenesis. BMP induce 
the production of bone when injected into ectopic sites. PDL human 
fibroblast attached to MTA produce an osteogenic phenotype, which 
reflects up-regulation of the expression of alkaline phosphatase, 
osteonidogen, osteonectin, and osteopontin (42). 
 Forms hydroxyapatite (or carbonated apatite) on the surface of MTA 
and provides a biologic seal. 
 
2.3 Clinical use of Mineral Trioxide aggregate as apical plug 
 
An MTA plug in the apical portion of the root forms a barrier that 
prevent the extrusion of the root filling material, the ensuing 
permanent bonded restoration increases fracture resistance of 
immature teeth and enhances the retention of natural dentition (46,47).  
Previous case series and prospective studies reported a high 
percentage of successful outcomes at one or two years follow-ups 
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when MTA was used as the apical plug in necrotic teeth with open 
apices (48-52). Different techniques for delivering MTA to the apical 
portion, time of therapy (one or more appointments), and use of 
intermediate medication with calcium hydroxide as intracanal dressing 
material have been proposed. The lack of both consensus regarding 
techniques and the limited follow-ups has encouraged the 
development of new studies (50-53). Only a few studies discuss at 
long time the clinical outcomes of the treatment of immature and 
necrotic teeth using MTA as an artificial apical barrier. The 
percentage of clinical and radiographic success of MTA apexification 
range is variable from 68.4% to 100% with a maximum median 
follow-up of 30.9 months (48,49,54, 55).  
The long term outcome of this treatment was documented in a clinical 
study performed, in the last ten years, at department of Endodontics at 
University of Florence (56). 
The clinical success of the apical plug technique was, in general, 
judge using PAI score in association to clinical signs and symptoms:  
 
 PAI score ≤ 2 and the absence of signs and symptoms was associated 
to a heling case;  
 PAI 3 or 4 with score improved at follow-up from immediate post-
treatment radiograph without signs and symptoms was associate to an 
healing case;  
 failure was diagnosed when signs or symptoms were present or the 
PAI was > 4 ( 7-10). 
Sometimes the results basing on clinical and radiographic criteria 
were dichotomized as healed or disease (55).    
The clinical protocol of the treatment of immature necrotic teeth could 
have different approach but in all cases, the necrosis of the teeth imply 
the presence of infected pulp. In immature teeth cleaning and shaping 
of the root canal system challenging because of the thin dentinal walls, 
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the disinfection could be achieved with calcium hydroxide and 
currently root canal irrigation; sodium hypoclorite and EDTA (49). 
Antibacterial action of calcium hydroxide is directly proportional its 
strong alkalinity; Sjӧgren at al. (57) showed that calcium hydroxide 
for seven days was highly effective in killing root canal flora, but for 
long time it may denature the carboxylate and phosphate groups 
leading to a collapse in the dentine structure. Until Cvek in 1992 
underlined as long-term apexification with calcium hydroxide 
reduction the root strength make the teeth more susceptibility to the 
fracture (58). Andreasen et al. reported that immature roots that had 
Ca(OH)2 placed within the root canal for 100 days showed a 
significant reduction in fracture resistance versus control; but up to 4 
weeks of calcium hydroxide did not adversely affect the fracture 
resistant (59). The dentinal strength is determined by the link between 
hydroxyapatite and collagenous fibrils. The high alkalinity of calcium 
hydroxide may denature the carboxylate and phosphate groups leading 
to a collapse in the dentin structure. The pre-treatment use of calcium 
hydroxide before the application of apical plug of MTA could 
adversely influenced the formation of apical barrier. In in vivo animal 
study, Felippe et al. showed no significant differences in the formation 
of apical tissue barrier, bone and root resorption, and the presence of 
microorganisms between the two experimental groups: teeth treated 
with CH pretreatment and apical plug with MTA and teeth treated 
without CH pretreatment. In addition, their findings determined that 
placing MTA alone results in more complete apical barrier formation 
compared and they further demonstrated that the amount of MTA 
extrusion was significantly higher in samples pretreated with CH 
compared with those without CH pretreatment (60). 
The main clinical drawbacks of MTA, when used as apical plug, 
include a difficult handling characteristics, long setting time, an 
absence of a known solvent for this material, and the difficulty of its 
removal after curing. The long setting time of MTA is one of the 
reasons that MTA should not be applied in 1 visit. This has been cited 
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as one of the shortcomings of this material. There is no known solvent 
for set MTA; presumably, MTA cannot be removed from the root 
canal when it is used as an apical barrier or root canal filling material. 
An investigation using both rotary file and ultrasonic devices for 
retreating root canals filled with WMTA as a root canal filling 
material demonstrated the inability of these devices to completely 
remove set MTA. Finally handling of MTA is not simple for some of 
its clinical applications and requires practice; in particular in case of 
long immature root where the carrier can not arrive in the apical 
portion; for a correct adaptation of MTA to the canal walls the use of 
microscopic device is usually required.  
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Chapter 3 
 
 
3.1 Dental stem cell; apexogenesis and apexification 
 
Necrosis of dental pulp in immature permanent teeth before complete 
root development poses a clinical challenge. As previously described 
apexification with calcium hydroxide and/or MTA apical plug 
technique enable the formation of a calcified barrier or an artificial 
barrier, respectively, at the root apex of canal system. Both technique 
is able to stimulate regeneration of pulp tissue, and continued root 
development, so the risk of fracture in a tooth with thin dentine walls 
remains. Cervical root fracture was markedly higher in endodontic 
treated immature teeth than in mature teeth and the range of incidence 
recorded is from 27% to 77% basing to the stage of root development 
(1). Postnatal stem cells with the capacity to self-replicate and 
differentiate into specialized tissue types have been identified in 
dental tissue. The tooth with immature apices, by regenerating tissue, 
could restore the physiologically functional dentition.   
Regeneration of dentin relies on having vital pulps; however, 
regeneration of pulp tissue has been difficult as the tissue is encased in 
dentin without collateral blood supply except from the root apical end. 
Attempts to regenerate pulp tissue have been a long quest. With the 
advent of modern tissue engineering concept and the discovery of 
dental stem cells, regeneration of pulp and dentin has been tested. 
Moony and Rutherford conduct the first team that initiated the testing 
of pulp tissue engineering (36-38). This attempt arrested due to the 
lack of isolation and characterization of pulp stem cells that 
potentially may differentiate into odontoblasts. Regenerated pulp 
tissue should be functionally competent, e.g., capable of forming 
dentin to repair lost structure.  
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Gronthos et al. demonstrated in vivo the ability of pulp cells to 
generate dentin, human pulp/dentin complex can be formed 
ectopically in immunocompromised mice (39). This discovery has 
promoted the investigation on the stem cell-based regenerating 
pulp/dentin for clinical applications. 
In the early 1960s, Nygard Ostby (2) showed that new vascularized 
tissue could be induced in the apical third of the root canal of 
endodontically treated mature teeth with necrotic pulps and apical 
lesions. This was accomplished by the creation of a blood clot in the 
apical third of a cleaned and disinfected root canal by using an 
apically extended root canal file just before root canal filling. He 
proposed that through formation of a clot (scaffold), a vasculature 
could be established to support growth of new tissue into the unfilled 
portion of the root canal. Teeth that had been treated following this 
procedure provide provided histologic evidence in support of his 
concept. In order to validate this hypothesis Myers & Fountain, in 
1974, reported an increased root length and calcified material in 
necrotic canals of monkey canines with immature apices after 
disinfection with NaOCl and filled the canals with citrated whole 
blood or gel foam (3). The hard deposition of hard tissue in the root 
canals has also been shown in reimplanted teeth after traumatically 
avulsion (4,5).  
It appeared that the non-vital pulp acted as a matrix into which the 
new blood vessels and tissue could grow (5,6).  
In 2001, Iwaya et al. (7) described a procedure, which they termed 
revascularization used in a necrotic immature mandibular second 
premolar with a chronic apical abscess. After 30 months they 
observed thickening of the root canal walls by mineralized tissue and 
continued root development. Subsequent even Banchs and Trope 
reported a successful case of revascularization procedure for the 
treatment of a necrotic teeth with large apical lesion (8). 
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3.2 Dental pulp stem cells 
 
The first element of tissue engineering is a source of cells capable of 
differentiating into the desired tissue component. Interestingly, stem 
cells are found in dental pulp (17, 18), in the apical papilla (19, 20), 
and even in the inflamed periapical tissue collected during endodontic 
surgical procedures (inflamed periapical progenitor cells) (21). These 
findings suggest an opportunity for harvesting stem cells during 
clinical procedures. Indeed, the evoked bleeding during endodontic 
regenerative procedures conducted on immature teeth with pulpal 
necrosis reveals a massive influx of mesenchymal stem cells into the 
root canal space (22).  
The dental pulp is soft tissue of ectomesenchymal and mesenchymal 
origin that develops from the dental papilla. Mesenchymal Stem Cells 
(MSCs) are defined by the International Society for Cellular Therapy 
as cells that express the molecular markers CD73, CD90, and CD105 
and lack expression of CD45, CD34, CD14 or CD11b, CD79a or 
CD19 and HLA-DR surface molecules (14). It has been shown that 
stem cells are a heterogeneous population of cells, and their molecular 
profile is very dynamic because of their ability to express a plethora of 
other markers depending on their differentiation, activation, or 
passage (Tab. 1). Dental-tissue-derived MSC-like populations are:  
 dental pulp stem cells (DPSCs),  
 stem cells from human exfoliated teeth (SHED), 
 stem cells of the apical papilla (SCAP), 
 periodontal ligament stem cells (PDLSCs), and 
 dental follicle progenitor stem cells (DFPSc),  
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Cell Type In Vitro Activity  
DPSCs Osteo/Dentinogenic 
Adipogenic 
Chondrogenic 
Myogenic 
Neurogenic 
SHED Dentinogenic 
Adipogenic 
Chondrogenic 
Myogenic 
Neurogenic 
Osteo-inductive 
SCAP Dentinogenic 
Adipogenic 
Chondrogenic 
Myogenic 
Neurogenic 
PDLS Osteo/Cementogenic 
Adipogenic 
Chondrogenic 
Myogenic 
Neurogenic 
DFPC Cementogenic 
Odontogenic 
Adipogenic-
Chondrogenic 
Myogenic 
Neurogenic 
 
Table 1. Multiple differentiation property of Human Dental Stem 
Cells. 
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Figure 1. Histologic section of human apical papilla and dental pulp. 
Huang GTJ et al. Mesenchymal Stem Cells derived from dental tissues vs. those from other sources: their 
biology and role in regenerative medicine. J Dent Res 2009;88:792-806. 
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Figure 2. Potential for secretion of trophic and immunomodulatory 
factors and from stem cells/progenitors.  
Nakashima M. et al Dental pulp stem cells and regeneration. Endod Topics 2013;28:38–50. 
 
 
During the development of root and the dental pulp, the dental papilla, 
located apically, demonstrated the capacity to developing pulp.  
SCAP are a population of dental stem cells that hold great potential in 
regenerative endodontics (20). These cells are believed to be the main 
source of undifferentiated cells in the process of root development 
(20), have greater proliferation rates than dental pulp stem cells (15, 
20), and have been previously differentiated in odontoblast-like cells 
resulting in the de novo production of dentin in vivo (16). Apical 
papilla tissue is clinically gelatinous and easily detached from the 
apex. Histologically, the apical papilla is distinctive from the pulp by 
a cell-rich zone and for a minor contents of cellular and vascular 
components. SCAP stem cells are present in a quiescent stage when 
present in their niche; once activated or released from their niche, 
these cells undergo significant changes, adopting a molecular profile 
dictated by environmental cues.  
The dental follicle surrounding the developing tooth root contains 
progenitor cell for the developing of periodontum (cementum, 
alveolar bone and PDL); whilst the inner and outer enamel epithelia 
fuse form the Hertwig epithelial root sheath (HERS).  
Postnatal population of human dental pulp stem cells has been 
identified and isolated, they have the ability to differentiate into 
odontoblast-like cell which express the early odontoblast cell marker, 
dentine sialophosfoprotein, and can form a dentin complex (17). 
DPSCs were capable to regenerate a dental-pulp-like complex 
composed of soft-fibrous tissue, mineralized matrix and odontoblast-
like layer able to deposit reparative dentin-like structure on the surface 
of human dentin (30-32). A stem cell-based approach in regenerative 
Endodontics needs to full fill the requirement of regenerating dental 
pulp in the whole three-dimensional geometry of root canals. In case 
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of necrotic and immature teeth the perivascular stem cell in niches 
located in the apical papilla, suspected of giving to new hard tissue 
and root formation (33, 34), moreover other authors suggest the 
possibility that stem and progenitor cell could came from the 
periodontal ligament and when bleeding occur could be enter in the 
root canal (35). 
Laceration of the apical papilla in patients triggers an in flow of blood 
into the root canal space that has a concentration of mesenchymal 
stem cell markers (CD73 and CD105) from 400-fold to 600-fold 
greater as compared with concentrations of these cells circulating in 
the patient’s systemic blood. Thus, several local sources of stem cells 
are available for clinical dental procedures, and stem cells can be 
delivered into the root canal system of patients. When bleeding 
occurs, mesenchymal stem cells from the bone marrow and 
periodontal ligament may transplanted into the root canal (20). After 
bleeding a blood clot that forms inside the root canal represents a rich 
source of growth factors that may play an important role in the 
regeneration process: differentiation, growth and maturation of 
fibroblast, odontoblast and cementoblast.  
Infact the second element of tissue engineering focuses on growth 
factors or other tissue-inducing mediators. Stem cells have the 
capacity to differentiate into a number of cell phenotypes depending 
on their lineage and exposure to environmental stimuli such as growth 
factors, extracellular matrix, hypoxia, or other conditions (18,20-26). 
Thus, the environment is a critical factor in regulating tissue 
differentiation. When lacerating the apical papilla appended a high 
local concentration of stem cells into the root canal space may not be 
sufficient to guide their differentiation into cells of the pulp-dentin 
complex. Instead, growth factors should be considered as important 
adjuncts. This is an important concept to remember when interpreting 
histologic studies after regenerative procedures. 
Growth factors are proteins that bind to receptors on the cell and 
induce cellular proliferation and/or differentiation. Many growth 
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factors are quite versatile, stimulating cellular division in numerous 
cell types, while others are more cell specific. Growth factors play a 
role in signalling many events in pulp-dentine regeneration. Two 
important families of growth factor that play a vital role are 
transforming growth factor (TGF) and bone morphogenetic protein 
(BMP). TGF-β1 and β3 are important in cellular signalling for 
odontoblast differentiation and stimulation of dentin matrix secretion. 
These growth factors are secreted by odontoblasts and are deposited 
within the dentin matrix, where they remain protected in an active 
form through interaction with other components of the dentin matrix.  
The addition of purified dentin protein fractions stimulates an increase 
in tertiary dentin matrix secretion suggesting that TGF-β1 is involved 
in injury signalling and tooth-healing reaction. 
BMPs induce higher quantity and more homogeneous reparatory 
dentin with the presence of many tubes with defined odontoblastic 
process as compared to that with calcium hydroxide. 
BMP-2, BMP-4 and BMP-7 have been shown to direct stem cell 
differentiation into odontoblasts and result in dentin formation making 
the BMP family the most likely candidate as growth factors.  
The third element of tissue engineering is a scaffold. A scaffold is 
much more important than simply forming a three-dimensional tissue 
structure. In addition, scaffolds play a key role in regulating stem cell 
differentiation by local release of growth factors or by the signalling 
cascade triggered when stem cells bind to the extracellular matrix and 
to each other in a three-dimensional environment (40,41). 
Scaffolds may be endogenous (eg, collagen, dentin, PRP, PRF) or 
synthetic substances (eg, hydrogels, MTA, or other compounds) (77, 
78). This principle may play a very important role in interpreting 
clinical regenerative studies. For example, instrumentation of dentin 
cylinders that was followed by irrigation with 5.25% NaOCl and 
extensive washing led to a dentin surface that promoted differentiation 
of cells into clastic-like cells capable of resorbing dentin (71). In 
contrast, irrigation of dentin cylinders with 17% EDTA either alone or 
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after NaOCl treatment produced a dentin surface that promoted cell 
differentiation into cells expressing an appropriate marker for a 
mineralizing phenotype (eg, dentin sialoprotein) (41). Accordingly, 
the selection of irrigants and their sequence (EDTA last) may play 
critical roles in conditioning dentin into a surface capable of 
supporting differentiation of a desired cell phenotype. 
 
 
3.3 Regenerative endodontic procedure: revascularization, 
revitalization or maturogenesis? 
 
The American Association of Endodontics define the term 
Regenerative Endodontic Procedure (REP) as follow: 
“Regenerative endodontic procedures are biologically based 
procedures designed to physiologically replace damage tooth 
structure including dentin and root structure as well as cell of the pulp 
dentin complex.” (Glossary of Endodontic Terms). 
REP are all the procedure aimed to restore damage pulp by 
stimulation of existing stem and progenitor cell present in the root 
canal and/or the introduction and stimulation of new stem and pulp 
progenitor cell into the root canal under condition that are favourable 
to their differentiation and reestablishment of function.  
The literature reports high number of studies with heterogenic term, 
the newest in general report “regenerative endodontics” as key word 
or in the title, but before it was not unusual find title with the term 
revitalization or revasculation. 
Considering that the nature of the tissue formed posttreatment was 
unpredictable and that the only certainty was the presence of blood 
Trope chosen the term revascularization (9).  Huang and Lin (10) 
supported the use of revascularization only in case of traumatized 
teeth (10); in case of no traumatic necrotic teeth the term induced or 
guided tissue generation and regeneration has been suggested. 
Subsequently Lenzi & Trope suggest the term revitalization and 
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Weisleder & Benitez maturogeneis (11, 12); the last definition was in 
accord to Hargreaves who explained the importance to describe 
continued root development in contrast to apexogenesis (13). 
Regenerative endodontic protocols, also referred to as 
revascularization processes in infected, immature teeth with necrotic 
pulps contemplate the continuation of full root development and 
thickening of the root walls in immature permanent teeth with pulp 
necrosis (51). 
The successful revascularization of immature teeth with apical  
periodontitis is mainly dependent upon: 
 
 Canal disinfection:  
The development of an endodontic infection plays a critical role in 
treatment considerations and the success of regenerative procedures. 
The knowledge of bacterial biofilm, the microbial virulence, adhesion 
characteristics, and the antibiotic sensitivity of the organisms involved 
would assist in identifying the best antibacterial strategies. For most of 
the research performed in the 20th century, culturing of root canal 
microflora was the state of the art, and clinical decisions were 
frequently based on cultivation results.  Nowadays several generations 
of molecular technologies have led to a dramatic improvement in 
knowledge of endodontic microbiology. Older molecular studies 
merely investigated the presence of organisms that had been identified 
by culturing or used the inefficient and expensive cloning and 
sequencing methodologies (52).  
Three endodontic microbiome in three different locations could play 
an important role in the endodontic infection: microflora in normal 
oral cavity, in necrotic root canal space, and in apical abscess. For 
example it can be seen from the differential abundance of microbiota 
how the proportion of streptococci and Veillonella spp., which are 
very abundant in the oral cavity, decrease in endodontic infections and 
the abundance of gram-negative anaerobes such as Fusobacterium 
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spp., Prevotella spp., and Porphyromonas spp. and the gram-positive 
Parvimonas spp. increase.  
There should be some selectivity in the choice of antimicrobial agents, 
given what is known about the nature of endodontic infections.  
In case of treatment of teeth with immature apex a very thin dentinal 
wall, minimal mechanical instrumentation is advocated so as not to 
further weaken the tooth structure. However, it is important to note 
that without the frictional force applied by a file to dentinal wall, 
bacterial biofilms remain intact and are much more resistant to 
antimicrobial agents than if they were rendered planktonic by this 
mechanical disruption. Therefore, a small amount of filing is 
performed, the intent of which is not to shape the root canal (such in 
mature teeth) but rather to create inroads through the biofilm to allow 
maximum permeation by the antimicrobials. 
Moreover although maximum antimicrobial efficacy is needed to 
prevent bacterial irritation of the revascularized/regenerated tissue, 
minimal toxicity of these antimicrobials on the soft and hard tissues 
surrounding this newly formed tissue is critical. For example, it is 
known that 2.5%–5.25% sodium hypochlorite and 2% chlorhexidine 
are among the most effective antimicrobials in nonsurgical endodontic 
treatment of teeth with mature apex. However, in vitro and animal 
model studies have shown that these materials at these concentrations 
may be toxic to stem cells of the apical papilla (33), may prevent 
adhesion of stem cells to dentin (53), and may abrogate the bioactivity 
of growth factors sequestered  in dentin (52). Therefore, of these 
agents, current clinical guidelines advocate only the use of 1.25% 
sodium hypochlorite at the first clinical appointment. 
The use of antibiotics becomes the obvious next choice because of 
their selectivity, their relatively reduced toxicity, and their potential 
residual effect while the tissue is growing. Several different antibiotics 
and antibiotic combinations have been proposed. The most widely 
used is triple antibiotic paste (ciprofloxacin, metronidazole, and 
minocycline), which was historically introduced after trials on root 
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canal cultivable microflora (54-56). Triple antibiotic paste has been 
found in an animal in situ study to disinfect 70% of root canals 
compared with only 10% disinfected by 1% sodium hypochlorite (57). 
However, because of the staining effect of minocycline, it was 
replaced with cefaclor (51) or eliminated altogether (7). Augmentin 
(GlaxoSmithKline, Philadelphia, PA) was used in a recent report (58) 
because it has been shown to be most effective against root canal flora 
(59, 60), it has the clavulanic acid that inactivates beta-lactamases that 
are prevalent in endodontic infections (59), and Augmentin does not 
discolour teeth.  
A creamy mix of antibiotics in a powder form with water or another 
sterile fluid, as is commonly advocated, results in high concentrations 
of the antibiotics. These high concentrations have been recently found 
to be toxic to the stem cells of the apical papilla (61). Therefore, lower 
concentrations of the antibiotics need to be used, and work is currently 
underway to determine the concentrations that would achieve effective 
disinfection with the least toxicity to the apical regenerative tissue. 
Interestingly, calcium hydroxide was not found to be toxic in the same 
study (61). This medicament has been found to provide clinically 
acceptable results in many case reports and case series (62, 63), and so 
it provides an important alternative to be considered. 
 
 
 
 Scaffold placement in the canal for the growing tissues.  
Once canal disinfection has been completed, the apex is mechanically 
irritated to induce clot formation, which will serve as a scaffold for 
tissue generation (8, 51). In any tissue engineering procedure, the cell 
growth and differentiation are related to an apposite scaffold (75-78). 
Extracellular matrix molecules (79) control the differentiation of stem 
cells. In this regard, it is anticipated that a suitable scaffold that 
contains growth factors might be promising tool to enrich the rate of 
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tissue differentiation as it would selectively bind and localize cells and 
undergo biodegradation over time (13). 
Intracanal blood (vs circulating blood) obtained from the laceration of 
apical tissue have high levels of stem cell markers (22). In addition, 
the blood clot may serve as a matrix for the growth of new tissue (8, 
64) as well as a source of growth and differentiation factors (65–67). 
Alternatives to a blood clot include platelet rich plasma (PRP) (7) and 
autologous fibrin matrix (AFM) (68). PRP and AFM contain growth 
factors that, along with other beneficial actions, initiate vascular 
ingrowth, induce cell differentiation, and improve soft- and hard tissue 
wound healing (69–72).  
The platelets release growth factors that are trapped inside the fibrin 
matrix following activation. These are considered to be the stimulant 
for response in the periosteum and are responsible for bone repair 
during normal wound healing. Nevertheless, there is still concern 
linked to the procedures for production of autologous fibrin adhesives. 
Besides, legal restrictions on blood handling with concentrated 
platelet rich plasma have coexisted. In an effort to overcome these 
problems, it was contemplated to develop a new family of platelet 
concentrates, which came to be recognized as the platelet rich fibrin 
(PRF). PRF consists of an intimate assembly of cytokines, glycan 
chains, structural glycoproteins enmeshed within a slowly 
polymerized fibrin network.17 These biochemical components have 
well known synergistic effects on healing processes (80) Fibrin is the 
natural guide of angiogenesis. Fibrin constitutes a natural support to 
immunity (81). 
Keswani et al. reported that PRF might serve as a potentially ideal 
scaffold in revascularization of immature permanent teeth with 
necrotic pulps as it is rich in growth factors, enhances cellular 
proliferation and differentiation, and acts as a matrix for tissue 
ingrowth (82). 
Shivashankar et al. reported a case of revitalization of tooth with 
necrotic pulp and open apex using PRF (83). They described evidence 
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of continued thickening of the dentinal walls, root lengthening, 
regression of the periapical lesion and apical closure with use of PRF. 
The authors considered PRF to be an excellent biomaterial for 
pulpdentin complex regeneration. Analogously, Rudagi et al. also 
reported a case demonstrating the successful healing and apexification 
with combined use of MTA as an apical barrier, and autologus platelet 
rich fibrin membrane as an internal matrix (84). 
A potential disadvantage of using either PRP or AFM is that they 
require a blood draw, which may be intimidating to practitioners and 
patients. It is worth mentioning that some authors have reported 
continued root growth in cases in which they were not able to achieve 
a blood clot in the canal space (74,75). This suggests that although a 
blood clot may increase the likelihood of favourable outcomes, it may 
not be necessary. 
 
 
 Bacteria-tight sealing of the access aperture:  
The access cavity is restored using a material that seals it against 
bacteria. In most studies, the materials of choice are ProRoot mineral 
trioxide aggregate (MTA) glass–ionomer resin. MTA has been shown 
to prevent coronal bacterial filtration, is biocompatible with the 
adjacent pulp tissue, induces the proliferation of pulp cells, raises the 
pH during prolonged periods of time and allows exceptional marginal 
adaptation, finally it can set in the presence of blood and, once set, is 
highly resistant to penetration by bacteria (85). 
However other materials has been used for access sealing, such as 
glass–ionomer or silver amalgam  and recently calcium-enriched 
mixture (CEM) cement, placed over the blood clot instead of MTA. 
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3.4 Nature of tissues present in the canals of these teeth treated with 
regenerative endodontics 
 
Root development consists of 3 parts: an increase in root wall 
thickness, an increase in root length, and the narrowing of the canal 
apically leading to the formation of the root apex. Vital pulp tissue 
inside the root canal is presumably necessary for an increase in root 
wall thickness because the canal becomes thinner. An increase in root 
length and the formation of the apex are functions of the apical papilla 
and Hertwig epithelial root sheath. 
Based on these guidelines, many success in vitro and in vivo studies 
have been reported in literature (43, 44). Recently, Torabinejad and 
Faras (45) presented clinical, radiographic, and histologic findings 
showing "pulp-like vital connective tissue" from a tooth after 
regenerative endodontic treatment done using platelet rich plasma 
(PRP) as a scaffold. Examinations of hematoxylin-eosin–stained 
sections revealed the presence of a mildly cellular fibrous connective 
tissue, fibroblasts, and  blood vessels. A few lymphocytes were 
observed in the specimens, and there was no evidence of odontoblasts 
in the sections examined. The specimens contained some small 
scattered round to irregular-shaped granular basophilic material 
partially surrounded by a few flattened multinucleated foreign body–
type giant cells. 
Examination of the soft tissue removed from the canal showed the 
absence of any signs of severe pathology. The presence of a few 
inflammatory cells in the periphery of the specimens and scattered 
small calcific materials could be because of the reaction of the pulp-
like tissue to the external irritants. 
The removal of the soft tissue without its surrounding hard tissues 
such as dentin does not allow good orientation and the identification 
of cells that had thickened the root of this tooth after regenerative 
endodontic procedures. Cells (such as odontoblasts or odontoblasts-
like cells) that had thickened the root after regenerative endodontic 
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procedures could have been left on the surfaces of the hard tissue 
during tissue extirpation using a barbed broach. Animal studies are 
needed to confirm these speculations. 
These findings indicated that these types of tissues are not of pulpal 
origin and the whole revitalization process is not tissue regeneration 
but tissue repair. 
Similar histological report was presented by Shimizu et al. from a 
tooth extracted after the completion of regenerative endodontic 
treatment in which more than one half of the canal was found filled 
with pulp-like loose connective tissue (46). Positive response to cold 
and/or electric pulp tests occurs in some cases (47). These findings 
indicate the success of regenerative endodontic procedures. 
In contrast to this, literature also reports some cases in which despite 
following proper protocol, pulp regeneration and root development 
failed. Lenzi and Trope (48) found empty root canal space after 
treatment of an immature maxillary central incisor with a necrotic 
pulp. Nosrat et al.(42) showed the absence of vital tissue inside the 
root canal space of treated immature maxillary incisors with necrotic 
pulps after 6 years. Nosrat et al (49) presented a case where root 
maturation occurred in a maxillary central incisor, even though a 
regenerative endodontic procedure resulted in an empty root canal 
space. Even after using tissue engineering strategies, cementum-like 
hard tissue was deposited on root canal walls, and bony islands were 
found throughout the root canals. 
Formation of a hard-tissue barrier inside the canal between the coronal 
MTA plug and the root apex (50) is another reported unfavourable 
outcome.  
Results from in vivo animal studies using similar protocols with an 
induced blood clot in the canal suggest that the regenerated tissue is 
not pulp tissue but, in fact, repair tissue consisting of bone, cementum, 
and inflammatory tissue (67–70). Even in case of failure of 
regenerative endodontic in vivo human studies, the histology analysis 
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no pulp-like tissue characterized by the presence of odontoblast like 
cells lining the mineralized tissue was observed.  
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Chapter 4 
 
 
Regenerative endodontics: review of clinical protocols 
 
4.1 Introduction 
 
Regenerative endodontics can be defined as biologically based 
procedures aimed to promote the regeneration of damaged tissues, 
including dentine and root structure as well as cells of the pulp-
dentine complex (1). 
Successful operative protocol of regenerative endodontics is 
revascularization (1, 2). In case of non-vital, immature tooth with a 
wide apical opening this approach is performed to re-establish the 
vitality of the pulp. This allows the complete maturation of the root in 
term of wall thickening, root lengthening, apical closure and healing 
of periradicular lesions if present. 
The critical components identified to contribute to the successful 
outcome of this procedure are the stem cells, signalling molecules, and 
a 3-dimensional physical scaffold (3), without which an empty canal 
space would not support ingrowth of new tissues from the periapical 
area. Blood clot and collagen have been recommended and used as 
scaffold materials for revascularization (4).  
The literature reports different disinfection protocols with and without 
the use of a combination of antibiotic paste or intra-canal medication 
as calcium hydroxide.  
The necrosis of an immature teeth could be caused by carie, trauma or 
anatomical reasons as dens evaginatus/invaginatus. All these events 
and clinical conditions lead to an intra-canal infection.  
In 2013 Moreno-Hidalgo et al. (5) identified and reviewed the 
scientific evidence regarding regenerative endodontic protocols. Four 
human studies were included after applying the inclusion and 
exclusion criteria; they showed a substantially omogeneous results 
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concerning the irrigation (sodium hypochlorite with different 
concentration) and disinfection of the canals (Triple antibiotic paste); 
the use of different scaffold was not investigated.  
When an excellent disinfection of the canal was reached the grown, 
development and differentiation of stem cells and vasculature are 
active by a providing a framework scaffold that can also be infused 
with a variety of grown factors. Induced bleeding from the periapical 
area and the following blood clot commonly represents a natural 
scaffold with grown factors. Until 2001 for Iwaya S. blood 
represented a natural scaffold to promote the regeneration of the pulp 
tissue (6).  
Since a blood clot scaffold is not always possible, some research have 
begun examining other three-dimensional scaffold that can be 
constructed with or without bleeding.  After that different scaffold 
have been used in the regenerative treatment: Platelet-rich plasma 
(PRP), platelet-rich fibrin (PRF), plasma-rich in grow factors (PRGF), 
crosslinked collagen-hydroxyapatite scaffold and polymeric scaffold 
as poly (lactide co-glycolide)-polyethylene glycol (PLGA-PEG) 
nanoparticles developed for bone tissue engineering (7-10).  
As suggested in a recent pilot retrospective cohort study, Alobaid et 
al. advocated the need of more studies to better understand the true 
incidence of continued root development after revascularization 
procedures and the influence of patient and tooth factors such as the 
aetiology of pulpal necrosis (eg, trauma vs caries), age, size of apical 
foramen, presence, size and temporal persistence of periapical 
pathology, and so on (11). 
On the basis of these studies and case reports, this systematic review 
aimed to critically summarized the results of all human studies and 
compare the efficacy of the regenerative protocols for necrotic 
immature permanent teeth. 
Moreover a correlation between the cause of necrosis, the element 
type and the outcome of treatment has been investigated. 
Using PICOS terms, the following objective has been formulated:  
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P (Population): adults with at least immature necrotic teeth with or 
without periapical lesion. 
I (Interventions): any regenerative protocol used in necrotic teeth with 
immature root development to promote root development and healing 
of periradicular lesion if present. For example regenerative endodontic 
treatment with Platelet-rich plasma (PRP), or with Blood Clot and 
MTA etc.  
C (Comparison): no root development procedures or different root 
development procedures with blood clot (BC) and with the use of 
additional scaffold and growth factors. 
O (Outcomes): length root and thickness of dentinal walls, apical 
diameter. 
S (Study design): all human studies (case report, case series, Cohort 
study, Case Control Study and Randomized Controlled Trials RCT). 
 
This study has been written in accordance with the PRISMA statement 
for reporting systematic reviews and meta-analysis of studies that 
evaluate health care interventions. 
 
4.2 Material and Methods 
 
Eligibility criteria 
All human studies described the regenerative procedure in necrotic 
teeth with incomplete root development were included in this study; 
review articles, opinion articles and letters were excluded. All studies 
dealing only with the treatment of necrotic immature teeth with no 
procedure aimed to a continue root development (regeneration), apical 
plug technique and apexification procedure were excluded. 
Treatment protocol adopted were classified as follow basing the 
scaffold and grown factors used: 
 Blood clot (BC) and coronal seal with MTA (group 0); 
 PRP with or without BC and coronal sealing (group 1); 
 PRF with or without BC and coronal sealing (group 2); 
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 Other treatment protocol (group 3). 
Primary outcome variables were: root development defined as 
increase of root length and/or increase of thickness of dentin walls of 
the root and/or apical closure.  
Source and Search strategy  
The basis for this research were the PRISMA guidelines 
(www.prisma-statement.org), using the MEDLINE database until 
April 2015, and the Medical Subject Headings (MeSH). In addition, 
the OneSearch SBART databases were explored to find possible 
papers matching our established selection criteria. Hand searching on 
Journal of Endodontics and International Endodontic Journal from 
1999 to 2015 was conducted. The reference section of previous review 
articles, identified by electronic search, were scanned searched to find 
additional relevant articles. The search was limited to the English 
language.  
Eligibility of the articles, and the assessment of the list of reference 
scanned from hand and electronic search were performed by the same 
operators.  
Afterthought the full text was retrieved and the relevant studies 
selected were analysed following inclusion criteria; all the remained 
studies were discarded. 
The search strategy used in MEDLINE (Entrez PubMed, www. 
ncbi.nim.nih.gov) was: ‘regenerative endodontics’ or ‘regenerative 
endodontic’ or ‘revascularization procedure’. 
Data collection   
Data from eligible studies were extracted by the reviewer (VG) 
according to guidelines outlined by the Cochrane Collaboration. 
List of information extracted: 
Authors 
Years of publication 
Sample size 
Necrosis causes  
Scaffold and source of growth factors used  
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The variable was registered at patient level when reported. 
The authors of the original studies were not contacted for clarification. 
 
Summery measurement and planned method of analysis 
Since not all studies reported the increase of root length, root 
thickness and apical closure in real measure (mm) a scale was 
arbitrarily designed by the author as follow:  
Root canal length 
 complete development of root length LLT (0),  
 increase of root length LL + (1),  
 no increase of root length LL - (2). 
Dentinal walls thickness 
 complete development of dentinal walls thickness Ø T (0),  
 increase of dentinal walls thickness Ø + (1),  
 no increase of dentinal walls thickness Ø - (2). 
Apical root closure 
 complete apical closure AT (0),  
 increase of apical closure A+ (1),  
 no increase of apical closure A - (2). 
The frequency of each variable and the relative percentage were 
recorded overall and for each experimental group.  
The successful outcome of endodontic regeneration procedure were 
considered complete when the follow items were recorded: 
 absence of sign and symptoms; 
 absence of periradicular pathological radiolucency area; 
 root apical closure AT;  
 complete development of dentinal thickness ØT; 
 complete development of root length could recorded LLT.  
No failure results classified as satisfactory results were considered 
when the follow items were recorded: 
 absence of sign and symptoms; 
 absence of periradicular pathological radiolucency area; 
 improve or complete dentinal thickness (ØT, Ø+); 
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 improve or complete root length (LLT, LL+).  
The percentage of successful outcame has been calculated for each 
operative protocols using different scaffold and grown factors.  
The presence of correlation coefficient between the successful 
outcome and the type of treated teeth, and the causes of necrosis has 
been calculated using the Pearson correlation coefficient.  
The correlation coefficient where calculated between the type of teeth 
and the satisfactory, and cause of necrosis and satisfactory results (as 
before). 
 
4.3 Results 
Study selection 
The electronic search identified 293 titles, hand search 6 titles and 8 
titles were identified by through cross-referencing, for a total of 307 
articles.  
After the reading of title and abstract 247 articles were excluded 
because 2 of them were not inherent, and 245 were animal or in vitro 
studies. The full-text of sixty-two articles were investigated basing on 
the inclusion criteria (PRISMA) and classified as follows: 8 revision, 
3 RCT, 5 Cohort studies, 1 case control studies, 34 case report and 11 
case series studies.  
Three case report were excluded because one study was not available 
on line (Cehreli ZC1, Sara S, Aksoy B.  Revascularization of 
immature permanent incisors after severe extrusive luxation injury. 
Tex Dent J. 2012;7:675-81); one retrospective case series was not 
inherent to regenerative procedure but reported the outcome of cases 
treated with apexification with calcium hydroxide and the outcome of 
teeth treated with apical plug technique with MTA (Cheuch LH et al. 
Regenerative Endodontic Treatment for Necrotic Immature Permanent 
Teeth. J Endod 2009;35:160-64); and one case report has the purpose 
to evaluate whether regenerative endodontic procedures are able to 
deliver stem cells into the canal space of immature teeth in young 
patients and to identify the possible tissue origin for these cells 
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(Lovelace TW et a. Evaluation of the Delivery of Mesenchymal Stem 
Cells into the Root Canal Space of Necrotic Immature Teeth after 
Clinical Regenerative Endodontic Procedure. J Endod 2011;37:133–
138). An overview of the selection process was provided by flow 
diagram (Fig. 1). 
The 8 revision identified (5, 58-64) were excluded; a total of 51 
studies were analysed (2,3,6,7,9, 11-56). 
The causes of necrosis (trauma, caries, and dens 
evaginatus/invaginatus), and the type of element (anterior, premolar 
and molar) were recorded for all teeth treated included in the selected 
articles. 
Study characteristics 
In the 51 studies selected on a total of 357 treated teeth were analysed. 
For 20 teeth the authors (12) did not specified the type (anterior, 
premolar or posterior), for the remaining 337 teeth 24.3% were 
premolar (n°82), 2,4% were molar (n°8) and 73.3% were anterior 
teeth (n°247).  
In group 0 the results of apical closure were reported for 152 teeth, the 
results of root canal length were reported for 139 teeth and the results 
for dentinal walls thickness were reported for 160 teeth.  45 teeth 
(29.6%), after regenerative endodontics procedure with BC as 
scaffold, reported a complete apical closure; 79 teeth (52%) an 
improve of apical closure and 28 teeth (18.4%) an absence of apical 
closure. Four teeth (2.5%) reported a complete root length 
development; 131 teeth (82%) an improve root length development 
and 25 teeth (15.5%) an absence of root length development. Eight 
teeth (5%) reported a complete dentinal walls thickness development; 
130 teeth (81.3%) an improve of dentinal walls thickness and 22 teeth 
(13.7%) no improve of dentinal walls thickness. 
A complete successful outcome was recorded only in four teeth on a 
total of 151 (table 2). A satisfactory outcome was recorded in 135 
(89.4%). 
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In group 1 a total of 25 teeth were treated; the results of apical closure 
root canal length and dentinal walls thickness were reported for all 
teeth. 13 teeth (52%), after regenerative endodontics procedure with 
PRP as scaffold, reported a complete apical closure; 12 teeth (48%) an 
improve of apical closure and no teeth showed an absence of apical 
closure. Six teeth (24%) reported a complete root length and dentinal 
thickness development; a total of 18 teeth (72%) an improve root 
length and dentinal thickness development and one teeth (4%) an 
absence of root length and dentinal thickness development. 
A complete successful outcome was recorded in 5 teeth on a total of 
25 (table 2). A satisfactory outcome was recorded in 24.  
In group 2 the results of apical closure, root canal length and dentinal 
walls thickness were reported for 10 teeth. 7 teeth (70%), after 
regenerative endodontic procedure with PRF as scaffold, reported a 
complete apical closure and root length development; a total of 3 teeth 
(30%) an improve of apical closure and root length development, no 
teeth with an absence of apical closure and root length development 
were recorded. Four teeth (40%) reported a complete dentinal walls 
thickness development; a total of 6 teeth (60%) an improve of dentinal 
walls thickness no teeth with no improve of dentinal walls thickness 
were recorded. 
A complete successful outcome was recorded only in one tooth on a 
total of 10 teeth, but a satisfactory results was judge in all the treated 
teeth (table 2). 
The causes of pulp necrosis was specified only for a total of 259 teeth 
on a total of 357 teeth. In 10.4% of treated teeth, the necrosis was a 
consequence of caries, in 23.2% of treated teeth the necrosis has been 
observed in teeth with dens evaginatus/invaginatus, and finally in 
66.4% of treated teeth the necrosis happened after a dental trauma 
(table 3). 
No correlation has been recorded between the successful outcome of 
the therapy and the tooth type or the causes of pulp necrosis (table 4).  
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No correlation has been observed between a satisfactory results and 
tooth type or causes of pulp necrosis (table 5).   
 
4.4 Discussion  
 
Regenerative approaches gained the advantage over the apexification 
and MTA apical plug technique because they can allow for further 
root maturation in length and thickness by regenerated vital tissue. 
The present review aimed to identify if the use of different scaffold 
(BC, PRP, PRF) could significantly influence the outcome of 
regenerative endodontics treatment in necrotic immature teeth. In a 
review dealing with the outcome of endodontic regeneration 
treatments, Law (57) reported several challenges in interpreting the 
results.  
These challenges included variability in technique and recall period, a 
potential bias of only successful cases being reported, different 
methods to judge the successful outcome and the lack of consistent 
radiographic angulation between pre-treatment and follow-up 
radiographs. 
The standardization of radiographic images enabled the calculation of 
development root length, dentin wall thickness and apical closure.  
The major part of the articles included in this review are case report 
and case series studies with low level of evidence, one was a case 
control study and five cohort studies, only three RCT were found.  
Even selecting only the three RCT (9,17,35) the risk of bias following 
the Cochrane risk of bias tool are high: no study reported a low risk 
for all items.  
All the three RCT described a randomized assigned teeth for each arm 
of the study but only one (Bezgin et al. 17) reported the randomization 
methods; they assigned all odd numbered teeth to the PRP group and 
all the even numbered teeth to BC group. This method was judge by 
the author with high risk of bias.  
62 
 
Allocation concealment and blinding of participant and personnel 
were never mentioned. 
The blinding outcome assessment was judged with low risk of bias in 
Nagy et al. study (9) because two authors performed the measurement 
blindly but the article did not report the indication about the operator.  
In Bezgin et al. (17) study, the operator was blinded to the scaffold 
used in the treatment but it did not report who performed the 
measurement.  
Finally in Jadhav et al. (35) study, the outcome assessment was judge 
by two endodontists not involved in the study so the risk of bias was 
judged low. 
Incomplete outcome reporting was judged at low risk of bias only in 
Nagy et al. (9) study because they reported change in root length, 
dentinal wall thickness and apical closure in mm.  
Bezgin et al. 1(7) reported the outcome in term of % RRA 
(radiographic root area) without reported the initial and the final 
measure. This value did not give information in term of increase or 
decrease of length of the root and wall thickness.  
Jahvad et al. (35) judge satisfactory, good and excellent the apical 
closure, the root lengthening and the dentinal wall thickening without 
give a specific meaning at these categories.  
For this reason in order not to lose the information given by all articles 
selected in this review an arbitrarily classification of results collected 
were adopted and used for qualitative analysis. The outcome was 
judge successfully when a complete apical closure, root length and 
development of dentinal walls thickness (A 0, LL 0, Ø 0) has been 
reported. The total amount of successful outcome in all teeth collected 
in the present review was very low: 4.9%. This could be due to the 
incomplete data reported, and to a too strictly categories that identified 
the successful outcome. Similar percentage of success were recorded 
for all experimental group 1.5% when BL was used as scaffold, 1.9% 
when PRP was used as scaffold and 0.4% when PRF was used as 
scaffold. It is important to underline that this data could not be 
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significant because in a few number of teeth PRP and PRF has been 
used as scaffold (25 and 10 teeth respectively) respect the BC (151 
teeth).  
Scaffolds are used in regenerative procedures to provide a framework 
through which cells and a vasculature can grow (31). Several report 
have been demonstrated good success with BC scaffold in association 
with MTA (33, 50,51); besides it not always possible invoke bleeding 
in the root canals researchers have begun examining other three-
dimensional scaffold.  
Plated-rich plasma (PRP) and plated-rich fibrin (PRF) form a three-
dimensional network of fibrin which acts as a scaffold with 
concentrated growth micro molecules.  
PRF consists of an intimate assembly of cytokines, glycan chains, 
structural glycoproteins enmeshed within a slowly polymerized fibrin 
network. These biochemical components have well known synergistic 
effects on healing processes. Fibrin is the natural guide of 
angiogenesis. 
PRF can be considered as an appropriate scaffold for regenerative 
endodontics as it full fills all the properties as mentioned above. 
Satisfactory outcome where obtained in the few studies collected in 
this review dealing PRF has been used as scaffold (2, 3, 20, 40,36). 
Even when PRP were used as scaffold in the studies selected for this 
review (1,2,12,13,17,19,42,35) not failure were recorded. PRP has 
been used as scaffold in two RCT studies: Bezgin et al. (17) compared 
the use of PRP and BC as scaffold in necrotic single-rooted immature 
teeth, no significant difference in treatment outcome was found 
between the two protocols. Previously Jadhav et al. (35) reported 
significant better results in term of periapical healing, apical closure 
and dentinal walls thickness when the use of PRP was compared with 
the use of BL. 
A 30% of studies in which neither intracanal bleeding was evocated 
nor PRP or PRF was used, concern the use of different and 
heterogeneous scaffolds. Nevis & Cymerman (4) showed successfully 
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results when cross-linked collagen-hydroxyapatite material has been 
used as scaffold. It is an implant material that contained a three 
dimensional network of collagen fibrils covered with nanocrystals of 
hydroxyapatite. The presence of branching microchannels, within a 
solid collagen hydroxyapatite spong,e allows osteogenic cells, new 
blood vessels, and growth factors to better migrate into the scaffold 
and the healing infrabony defect.  
Bakhtiar et al. (22) showed the positive effects of plasma-rich in 
growth factor (PRGF) on development of pulp and apical closure in 
three cases reports. PRGF stimulate the Hertwig’s epithelial root 
sheath in addition to increasing phosphatase activity and promote the 
osteogenic differentiation. A newer class of biocompatible and 
biodegradable poly (lactide-co glycolide)-polyethylene glycol (PLGA-
PEG) nanoparticles developed for bone tissue engineering as a 
scaffold for SCAP cells. These hydrogels are injectable scaffolds that 
can be delivered by syringe in the apical portion of necrotic teeth with 
immature root development. Shiehzadeh V. et al. (10) reported the 
results of three cases. More simple procedure involved the use of 
Calcium Hydroxide alone. CaOH2 promote the recruitment, migration, 
proliferation and mineralization of dental stem cells. Park & Ahn (25), 
in necrotic teeth with open apices, after a copious irrigation with 
sodium hypochlorite and an intracanal medication with calcium 
hydroxide, limit to the coronal or half part of the canal, reported an 
apical closure and an increase of root canal thickness. 
The literature was very inconsistent on indications dealing with the 
use of different scaffold depending on different clinical condition. 
Only few in vitro study support the hypothesis that PRP may enhance 
wound healing only if the parenchymal tissue has not completely 
destroyed, due to the fast degradation of growth factors in PRP (60-
61). 
Finally, in the present review no correlation were found between the 
successfull outcome and type of element treated or causes of necrosis. 
Trauma is clearly an important contributory factor to the incidence of 
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immature permanent teeth with necrotic pulps because an estimated 
22% of children suffer trauma to the permanent dentition, with an age 
range peaking between 7 and 10 years, more frequently in males, and 
most commonly involving the maxillary central and lateral incisors 
(66).The situation is very different for a case with necrotic pulp and an 
established infection manifesting clinically as pulp necrosis with an 
acute or chronic abscess or a radiographically visible apical lesion. In 
these cases, the infection has been established for a sufficient duration 
to allow the development of bacterial biofilms inside the root canal. 
When the necrosis of the pulp is due to a trauma, after the beginning 
there is no infection or minimal contamination without an established 
bacterial biofilm. In this clinical circumstance host, responses will 
allow sufficient connective tissue to revascularize the pulp space 
through the relatively large apical foramen and continue 
mineralization, leading to increases in the width and length of the root 
(57). In case of traumatic injuries of immature teeth with no infection 
or minimal contamination without an established bacterial biofilm, the 
host responses will allow sufficient connective tissue to revascularize 
the pulp space through the relatively large apical foramen and 
continue mineralization, leading to increases in the width and length 
of the root. The success of revascularization after traumatic injuries of 
immature teeth has been shown to increase with the size of the apical 
foramen (65). 
In general anterior teeth are more susceptible to traumatic injury, carie 
are most common in posterior teeth. 
The correlation has been calculated between a satisfactory outcome 
(improve o complete root development, absence of clinical signs and 
symptoms, absence of periradicular lesion) and the tooth type 
involved or causes of necrosis. The use of only two variables, 
changing in root length and dentinal walls thickness, could be justified 
because these are the parameters that differentiate the outcome of  
regenerative procedure from apexification with calcium hydroxide or 
MTA apical plug technique. Apical root closure could be reach with 
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traditional apexification technique or with MTA apical plug 
technique.  
As previously reported by Jeeruptan et al. (38) and Bose et al. (62) a 
statistically significant difference in increase of wall dentinal 
thickness and root length between teeth treated with regenerative 
terapy and apexification with calcium hydroxide or MTA apical plug 
technique were found. Jeeruptan et al. (38) and Bose et al. (62) 
reported an increase of root length of 14.9%  and 48% in immature 
necrotic teeth treated with regenerative endodontic respectively.  
In the present study in teeth without signs and symptoms, and 
periradicular pathology, treated with regenerative endodontic 
procedure no correlation were found between the increase of dentinal 
walls thickness or root length and the type of treated tooth or the 
causes of necrosis. 
The type of teeth, anterior posterior or premolar, the causes of 
necrosis seems not influenced the outcome of regenerative endodontic 
treatment. No difference were found in terms of outcome using 
different scaffold in regenerative endodontic treatment. 
In conclusion, this review has several limitation: first of all the quality 
of the studies is very low. The section materials and methods often 
present bias for the description of PICOS terms. The major obstacle 
met has been represented by incomplete outcome data reported. RCTs 
adhering to the Consort guidelines could be encouraged to better guide 
the clinicians in the decision-making process. 
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Figure 1 strategy selection  
 
 
 
 
                                                               
 
Initial search basing on titles and abstract 
 
 
 
                                                             Inclusion criteria PRISMA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
293 articles identified in  
database screening 
6 articles studies identified 
in hand search 
               8 revisions  
34 case reports 
1 Case control study 
3 RCT 
11 case series 
5 cohort study 
 
 
62 of full-text articles assessed for 
eligibility  
8 revisions 
33 case reports 
3 RCT 
10 case series 
5 Cohort study 
(n=51) studies included in 
qualitative synthesis 
 
8 articles studies identified 
through cross-referencing 
articles in vitro, or animal studies, 
excluded. 
(n=245) 
Full text articles assessed for 
eligibility (=62)  
Total recorded screened 
(n=307) 
3 studies not 
inherent  
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             Table 1 Summary date collected from the studies selected 
 
 
Authors 
& journal 
Tooth 
type 
Cause 
necrosis Scaffold  
Walls 
thickness 
Root 
lenght 
Apical 
closure 
Jadhav J Nat 
sci biol Med. 
2015 1 
 
2 1 1 0 
Narag Cont 
Clin Dent 
2015 
  
3 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
3 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
3 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
3 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
3 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
1 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
1 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
1 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
1 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
1 1 1 1 
Narag Cont 
Clin Dent 
2015 
  
2 0 0 1 
Narag Cont 
Clin Dent 
2015 
  
2 0 0 1 
Narag Cont 
Clin Dent 
2015 
  
2 0 0 1 
Narag Cont 
Clin Dent 
2015 
  
2 1 0 1 
Narag Cont 
Clin Dent 
2015 
  
2 1 0 1 
Narag Cont 
Clin Dent 
2015 
  
3 2 2 2 
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Narag Cont 
Clin Dent 
2015 
  
3 2 2 2 
Narag Cont 
Clin Dent 
2015 
  
3 2 2 2 
Narag Cont 
Clin Dent 
2015 
  
3 2 2 2 
Narag Cont 
Clin Dent 
2015 
  
3 2 2 2 
Nagaveni 
Pediatr Dent 
2015 0 1 2 1 0 0 
Nevis J Endod 
2015 1 0 3 2 2 2 
Nevis J Endod 
2015 1 0 3 2 0 0 
Nevis J Endod 
2015 0 0 3 2 2 2 
Nevis J Endod 
2015 0 0 3 2 2 2 
Nevis J Endod 
2015 0 1 3 2 0 0 
Büyükbayram 
Case Rep 
Dent 2014 0 2 0 1 2 0 
Bezgin 
J Endod 2015  1 0 1 1 1 0 
Bezgin 
J Endod 2015 0 1 1 1 1 0 
Bezgin 
J Endod 2015 1 0 1 1 1 0 
Bezgin 
J Endod 2015 1 0 1 1 1 0 
Bezgin 
J Endod 2015 0 1 1 1 1 0 
Bezgin 
J Endod 2015 1 0 1 1 1 0 
Bezgin 
J Endod 2015 0 1 1 2 2 1 
Bezgin 
J Endod 2015 0 1 1 1 1 1 
Bezgin 
J Endod 2015 0 1 1 1 1 0 
Bezgin 
J Endod 2015 0 1 1 1 1 1 
Bezgin 
J Endod 2015 1 0 0 1 1 0 
Bezgin 
J Endod 2015 0 1 0 1 1 0 
Bezgin 
J Endod 2015 0 1 0 0 0 0 
Bezgin 
J Endod 2015 0 1 0 1 1 0 
Bezgin 
J Endod 2015 0 1 0 1 1 1 
Bezgin 
J Endod 2015 0 1 0 1 1 1 
Bezgin 
J Endod 2015 0 1 0 1 1 1 
Bezgin 
J Endod 2015 1 0 0 1 1 0 
Bezgin 
J Endod 2015 0 1 0 2 2 1 
Bezgin 
J Endod 2015 0 1 0 1 1 0 
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Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Saud J Endod 
2014 0 1 0 1 1 0 
Sachdeva Int 
J Endod 2014 0 1 1 1 1 1 
Johns J Cons 
Dent 2014 0 
 
2 0 1 1 
Johns J Cons 
Dent 2014 0 
 
2 0 1 1 
Saud J Endod 
2014 0 1 0 1 1 1 
Saud J Endod 
2014 0 1 0 1 1 1 
Bakhtiar NY 
State Dent 
2014 0 1 1 0 0 0 
Bakhtiar NY 
State Dent 
2014 0 1 1 0 0 0 
Bakhtiar NY 
State Dent 
2014 0 1 1 0 0 0 
Bakhtiar NY 
State Dent 
2014 0 1 1 0 0 0 
Polat Rest 
Dent Endod 
2014 1 
 
1 0 0 0 
Allobaid J 
Endod 2014 0 0 0 2 2 2 
Allobaid J 
Endod 2014 0 0 0 2 2 2 
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Allobaid J 
Endod 2014 0 0 0 2 2 2 
Allobaid J 
Endod 2014 0 0 0 2 2 2 
Allobaid J 
Endod 2014 0 2 0 1 1 1 
Allobaid J 
Endod 2014 0 2 0 1 1 1 
Allobaid J 
Endod 2014 0 2 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Allobaid J 
Endod 2014 0 1 0 1 1 1 
Shiehzadeh 
Indian J dent 
Res 2014 1 1 3 2 2 0 
iehzadeh 
Indian J dent 
Res 2014 0 0 3 2 2 1 
Park M 
Pediatr Dent 
2014 1 2 3 0 0 0 
Park M 
Pediatr Dent 
2014 1 2 
 
0 0 0 
Kumar J 
Endod 2014 0 2 3 1 1 0 
Kumar J 
Endod 2014 0 2 3 1 1 0 
Jadhav Case 
Rep Dent 
2014 0 1 1 0 0 1 
Kahler J 
Endod 2014 1 2 0 
   Kahler J 
endod 2014 0 1 0 1 1 1 
Kahler J 
Endod 2014 0 1 0 1 2 1 
Kahler J 
Endod 2014 0 1 0 1 1 1 
Kahler J 
endod 2014 0 1 0 2 2 1 
Kahler J 
Endod 2014 1 2 0 1 1 1 
Kahler J 
Endod 2014 1 2 0 1 2 1 
Kahler J 
Endod 2014 0 
 
0 1 2 1 
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Kahler J 
Endod 2014 0 
 
0 1 2 2 
Kahler J 
Endod 2014 0 1 0 1 1 2 
Kahler J 
Endod 2014 0 1 0 
  
2 
Kahler J 
Endod 2014 0 1 0 
   Kahler J 
Endod 2014 0 1 0 
   Kahler J 
Endod 2014 0 1 0 
   Kahler J 
Endod 2014 0 1 0 
   Kahler J 
Endod 2014 0 1 0 
   Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
0 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
 
3 1 1 1 
Nagy J Endod 
2014 0 
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Legend of descriptive table of the studies analysed (table 1). 
Tooth type: 0 anterior tooth, 1 premolar, 2 molar. 
Causes of necrosis: 0 carie, 1 trauma, 2 dens invaginatus/evaginatus. 
Scaffold: 0 blood clot and MTA, 1 PRP, 2 PRF, 3 other scaffold. 
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Walls thickness: 0 completed development of dentinal walls thickness, 
1 grown of dentinal walls thickness, 2 no improve od dentinal walls 
thickness. 
Root length: 0 completed development of root length, 1 grown root 
length, 2 no improve of root length. 
Apical closure: 0 completed apical closure, 1 improve of apical 
closure, 2 no apical closure. 
 
 
Table 2 Frequency of results of apical closure, root length and dentinal 
walls thickness in the experimental group. 
 
 
Variable Results  BC & MTA PRP PRF Other  Overall 
Apical A1 79/(52%) 12/(48%) 7/(70%) 40 138/(51.7%) 
 A2 28/(18.4%) 0/(0%) 0/(0%) 21 49/(18.4%) 
 A0 45/(29.6%) 13/(52%) 3/(30%) 19 80/(30%) 
Length LL1 131/(82%) 18/(72%) 3/(30%) 50 202/(57.5%) 
 LL2 25/(15.5%) 1/(4%) 0/(0%) 30 56/(16%) 
 LL0 4/(2.5%) 6/(24%) 7/(70%) 76 93/(26.5%) 
Thick Ø1 130/(81.3%) 18/(72%) 4/(40%) 59 211/(60.1%) 
 Ø2 22/(13.7%) 1/(4%) 0/(0%) 23 46/(13.1%) 
 Ø0 8/(5%) 6/(24%) 6/(60%) 74 94/(26.8%) 
Complete 
success 
outcome   
A0, LL0, Ø0 4 (2.6%) 5 (25%) 1 (10%) 80 (30.1%)  
 
 
Table 3 Frequency of cause of pulp necrosis and tooth type in the 
experimental scaffold 
 
 
 
Variable  BC & MTA PRP PRF Other  Overall 
Necrosis Carie 12/(4.6%) 4/(1.5%) 0/(0%) 11/(4.2%) 27/(10.4%) 
 DE 26/(10%) 1/(0.4%) 0/(0%) 33/(12.7%) 60/(23.2%) 
 Trauma 101/(39%) 13/(5%) 2/(0.8%) 56/(21.6%) 172/(66.4%) 
 Overall 139/(53.7%) 18/(6.9%) 2/(0.8%) 100/(38.6%) 259/(100%) 
Tooth Ant 129/(38.3%) 14/(4.2%) 4/(1.2%) 100/(29.7%) 247/(73.3%) 
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 Mola 8/(2.4%) 0/(0%) 0/(0%) 0/(0%) 8/(2.4%) 
 Prem 30/(8.9%) 6/(1.8%) 0/(0%) 46/(13.6%) 82/(24.3%) 
 Overall 167/(49.6%) 20/(5.9%) 4/(1.2%) 146/(43.3%) 337/(100%) 
 
 
 
 
Table 4 Correlation between successful outcome and tooth type or 
causes of pulp necrosis.  
 
Variable Correlation (p-value) 
Successful & toorh 
Pearson Corr = 0.08 ( p-value 
=0.2154) 
Successfull & necrosis 
Pearson Corr = -0.01 ( p-value 
=0.929) 
 
Table 5 Correlation between no failure outcome and tooth type or 
causes of pulp necrosis.  
 
Variable Correlation (p-value) 
No failure ( 00,01,10,11) 
& toorh 
Pearson Corr =-0.01 ( p-value =0.9037) 
No failure ( 00,01,10,11) 
& necrosis 
Pearson Corr =0.12 ( p-value =0.0672) 
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Summary and conclusion 
 
Chapters 1 and 2. 
The pulpal necrosis and arrest of root development makes the 
endodontic treatment in immature permanent teeth especially 
challenging (1). In this circumstance, in children the incorrect 
management can result in loss of permanent teeth, disorders of 
mandibular growth and masticatory function, and even speech 
disorders and facial cosmetic impairment (1,2). Apexification is a 
nonsurgical method of inducing a calcific barrier at the open root apex 
of necrotic teeth (1,2). The barrier prevents toxins and bacteria from 
entering periradicular tissue, and facilitates placement of a root canal 
sealant and filling material (3). Calcium hydroxide is commonly used 
for apexification, it has predictable results, and can be mixed with a 
number of different substances (camphorated mono chlorophenol, 
distilled water, saline, anesthetic solutions, chlorhexidine, and 
cresatin) to induce apical closure (1,2). Hermann  introduced the use 
of calcium hydroxide in endodontics in 1920 (4). Calcium hydroxide 
is a slow-acting antiseptic intracanal medication that needs a 24-hour 
contact period for the complete killing of enterococci and a 1-week 
contact period to achieve a bacterial reduction rate of 92.5% (5,6). In 
addition, calcium hydroxide has the ability to hydrolyze the lipid 
portion of bacterial lipopolysaccharide, resulting in inactivation of the 
biologic activity of lipopolysaccharide and subsequent cessation of 
lipopolysaccharide-induced inflammation in the periradicular tissue 
(7). In case of teeth treated with calcium hydroxide, a prolonged 
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period needed to form the apical barrier, and during the treatment 
period the teeth are susceptible to fracture. Besides risk of tooth 
fracture, calcium hydroxide has a number of limitations, the variables  
which can affect treatment outcomes are: treatment time ranging from 
5 months to 20 months; the apical closure in relationship to treatment 
time is unpredictable; long patient compliance due to the extended 
treatment time (1).  
To overcome these disadvantage of apexification with calcium 
hydroxide Mineral Trioxide Aggregate (MTA) has been 
recommended for such usage. MTA was introduced in 1993 by 
Torabinejad et al (8); it has excellent biocompatibility as well as 
sealing, osteogenesis, and cementogenesis abilities (9-11). MTA 
promote the formation of apatite-like crystals on the outer contact 
surface when exposed to body fluid (12); this ability was useful to seal 
the apical broad foramen in case of necrotic teeth with incomplete root 
development. Apexification with MTA, known as MTA apical plug 
technique, can be completed in one or two treatment sessions, making 
it possible to restore the tooth within a short timeframe while avoiding 
reliance on patient compliance and prolonged exposure of root dentin 
to calcium hydroxide (13-16). Clinical studies reported a percentage 
of healing range between 77% to 85% in necrotic teeth with 
incomplete root development treated with apical plug technique (13-
16); moreover the results obtained is stable at long term follow-up 
(17). As documented in our recent study complete healing was 
observed in 7 out of a total of 17 teeth at the one year follow-up, the 
cases of complete healing increased at five years (13 out of 16 teeth) 
and the results remained stable at 10 years (15 out of 16 teeth) without 
statistically significant differences. As per previous studies (16, 18, 
19) longer recall intervals (more than one year) could be an important 
factor for a better treatment outcome, particularly in cases of necrotic 
teeth with large periapical lesions (19, 20). Pace et al (17) obserevd a 
change in outcome from the time of initial therapy and the 1 and 5 
year recalls; the results remained substantially stable between the 5 
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and 10 year follow-ups. Only one case was documented as a failure 
(6%), this percentage could be significant in case studies with bigger 
sample sizes. The failure case, that was documented ten years after 
treatment, was associated with a longitudinal root fracture that could 
have been due to an immature thin and fragile root. As previously 
reported, dentin thickness that is correlated with the stage of root 
development, is one of the most important incidence factors in the 
frequency of tooth fracture (21). 
Despide the difference in steps protocol between apexification with 
calcium hydroside and MTA apical plug technique a recent meta-
analysis showed that both materials had similar clinical success rates, 
radiographic success rates, and apical barrier formation rates (22). 
However, MTA was associated with a significantly shorter time to 
achieve apical barrier formation than the Calcium Hydroxide. This is 
of great significance because many failures with calcium hydroxide 
are due to poor patient follow-up because of the extensive treatment 
time. Finally the same study revealed no statistical difference in term 
of radiographic success rate between the MTA group and the calcium 
hydroxide group, even only two studies, collected and examinated, 
reported radiographic success rate data. 
 
Chapter 3 
 
Regenerative endodontic procedures are defined as biologically based 
procedures aimed to replace damaged dentin and cells of the pulp–
dentin complex (23). Regenerative endodontics currently has two 
major concepts: guided tissue regeneration and tissue engineering 
(24). Guided tissue regeneration involved the tissue regeneration 
through the formation of a blood clot: revascularization; this concept 
was introduced for the first time by Nygaard-Ostby in the year 1961 
(25). Tissue engineering with stem cells is still developing. Both these 
concepts had the same goal: promote physiological pulp formation by 
activation of stem cells.  
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Iwaya et al. documented a successful response to vitality tests in 
treated necrotic immature tooth as well as root development after 
regenerative intervention (26). In this study a double anti-biotic paste, 
ciprofloxacin and metronidazole, has been used to reach a 
debridement of root canal and to promote the regeneration of the 
pulpal tissue. Afterwards Banch and Trope (27) developed a triple 
antibiotic paste consisting of ciprofloxacin, metronidazole, and 
minocycline placed in the canal for 28 days, after debridement with 
sodium hypochlorite (5.25%). At the second visit, after removed the 
antibiotic paste, bleeding was induced, and a filling was placed 
coronally to blood clot. The treatment demonstrated root development 
in terms of lenghing and thickness of the dentin root and a positive 
response to vitality testing. This studies opened a new era to the 
treatment of necrotic immature permanent teeth.  
Pulp Tissue regenerative procedure involved three essenzial 
components: (A) stem cells, (B) growth factors, and scaffolds (C). 
Stem cells from the dental pulp were identified based on their ability 
to regenerate a pulp dentin like complex (28); these were identified as 
dental pulp stem cells (DPSCs). The DPSCs included Stem Cells of 
the Apical Papilla (SCAP), Stem Cells of Human Exfoliated 
Deciduous teeth (SHED), and Periodontal Ligament Stem Cells 
(PDLSCs); all of these cells have potential for regeneration of pulpal 
tissue. DPSCs are multipotent cells with an ability to differentiate into 
adipocytes, osteoblasts, melanocytes, myoblasts and endothelial cells, 
produce mineralized tissue, and demonstrate neurogenic potential 
(29). 
SCAPs in the apical papilla of immature teeth have been postulated to 
differentiate into cells responsible for continued root development in 
pulpally damaged immature teeth with a retained apical papilla (30). 
Stem cells isolated from the remnant pulp of exfoliated deciduous 
teeth (SHED) have a higher proliferation rate and mineralization 
potential compared with DPSCs (30). They also demonstrate a higher 
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osteo-inductive capacity in vivo and have a higher neurogenic 
potential compared with DPSCs (31).  
Cells isolated from the periodontal ligament (PDLSCs) displayed 
osteogenic and differentiation potential in vitro (32), besides the 
potential to regenerate into cementoblast like cells, adipocytes, and 
collagen forming cells. They are present in all age groups but their 
regenerative potential, migration, and proliferation capacity decreases 
with age (33). With regenerative procedures, the growth and 
development of cell and vasculature are achieved by providing a 
network scaffold that can also infused with a variety of factors.  
Growth factors play a vital role in endodontic regeneration procedure 
they influence stem cell activity such as them proliferation, and 
differentiation into different lineage. They play an important role in 
the formation and repair of the dentin pulp complex. The 
Transforming Growth Factors (TGF) b are implicated in odontoblast 
differentiation, dentin matrix secretion, tooth development, and tissue 
repair (34). Bone morphogenic proteins (BMPs) play an important 
role in the pulp: BMP4 and BMP5 are expressed during ameloblast 
differentiation and BMP2, BMP4, BMP6, BMP7, and GDF11 (growth 
differentiation factor) during odontoblast differentiation (35). 
Angiogenesis is critical to the development and survival of the 
regenerated pulp. Examination of the dentin matrix shows high 
concentration of platelet derived growth factor (PDGF-AB), vascular 
endothelial growth factor (VEGF), fibro-blast growth factor (FGF), 
placenta growth factor (PIGF), and low concentration of epidermal 
growth factor (EGF).  
Finally for tissue engineering strategies, the choice of an appropriate 
scaffold is a crucial step; the role of the scaffold has changed from 
passive carrier toward a bioactive matrix, which can induce a desired 
cellular behavior.  
In dental- pulp complex regeneration procedure scaffolds are three 
dimensional network that serve as a template aiding development of 
tissue by providing regulatory molecules and mechanical support. 
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Scaffolds may be endogenous (eg, collagen, dentin) or synthetic 
substances (eg, hydrogels, MTA, or other compounds). The more 
common scaffold used in regenerative endodontic procedure include: 
the blood clot developed during revascularization and dentin chips 
(37-39); platelet rich plasma (PRP) and platelet rich fibrin (PRF).  
 
 
Chapter 4 
 
Background 
In case of necrotic teeth with incomplete root formation, the 
regenerative endodontics procedures aim to replace damage pulp-
dentin complex and normal pulpal physiologic functions that include 
root development and immunocompetency. These procedures are 
based on three principle of tissue engineering: appropriate source of 
stem cell; presence of growth factors for stem cell differentiation and 
an appropriate scaffold.  
Aim: the aim of the present study was to systematically analysed the 
Regenerative Endodontic protocols and the relative results of in vivo 
human studies. 
 
Methods 
An electronic search was conducted in PubMed using appropriate 
Medical Subject Heading terms (regenerative endodontics, 
regenerative endodontic) covering a period until to April 2015. 
Additional hand searching was conducted, and reference section of 
each relevant articles were included in the search. In order to 
identified the relevant articles the scanning of titles, abstracts and 
ultimately full texts were performed. Treatment protocol adopted were 
classified as follow basing the scaffold used: Blood clot (BC) and 
coronal seal with MTA (group 0); PRP with or without BC and 
coronal sealing (group 1); PRF with or without BC and coronal 
sealing (group 2); and other treatment protocols (group 3). The 
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frequency of the following variables: rooth canal length, dentin walls 
thickness and apical closure, and the relative percentage were 
recorded overall and for each experimental group.  
The successful outcome of endodontic regeneration procedure were 
considered complete when the follow items were recorded: absence of 
sign and symptoms; absence of periradicular pathological 
radiolucency area; root apical closure; complete development of 
dentinal thickness; complete development of root length.  
Satisfactory results were considered when the follow items were 
recorded: absence of sign and symptoms; absence of periradicular 
pathological radiolucency area; improve or complete dentinal 
thickness; improve or complete root length.  
The percentage of successful outcame has been calculated for each 
operative protocols using different scaffold.  
The presence of correlation coefficient between the successful 
outcome and the type of treated teeth, and the causes of necrosis has 
been calculated using the Pearson correlation coefficient.  
The correlation coefficient were calculated between the type of teeth 
and the satisfactory results, and the cause of necrosis and satisfactory 
results (as before). 
 
Results 
In the 51 studies selected a total of 357 treated teeth were analysed. 
152 teeth were classified in group 0; a complete successful outcome 
was recorded only in four teeth on a total of 151, and satisfactory 
outcome was recorded in 135. 
In group 1 a total of 25 teeth were treated, a complete successful 
outcome was recorded in 5 teeth on a total of 25, and a satisfactory 
results in 24 studies.  
In group 2 a complete successful outcome was recorded only in one 
tooth on a total of 10 teeth, but the outcome was judge satisfactory in 
all teeth. 
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The causes of pulp necrosis was specified only for 259 teeth on a total 
of 357 teeth. In 10.4% of treated teeth, the necrosis was a consequence 
of caries, in 23.2% of treated teeth the necrosis has been observed in 
teeth with dens evaginatus/invaginatus, and finally in 66.4% of treated 
teeth the necrosis was the result of a trauma. 
For 20 teeth the authors (12) did not specified the type (anterior, 
premolar or posterior), for the remaining 337 teeth 24.3% were 
premolar (n°82), 2,4% were molar (n°8) and 73.3% were anterior 
teeth (n°247). 
No correlation has been recorded between the successful outcome of 
the therapy and the tooth type or the causes of pulp necrosis.  
No correlation has been observed between a satisfactory results and 
tooth type or causes of pulp necrosis.   
 
Discussion  
The present review aimed to identify if the use of different scaffold 
(BC, PRP, PRF) could significantly influence the outcome of 
regenerative endodontics treatment in necrotic immature teeth. 
The major finding recorded by this research is the low level of 
evidence of the studies dealing regenerative endodontics and the wide 
and different methods used to judge the outcome of the therapy. For 
this reason in order not to lose the information given by all articles 
selected in this review, an arbitrarily classification of results collected 
were adopted and used for qualitative analysis. The outcome was 
judge successfully when a complete apical closure, root length and 
development of dentinal walls thickness (A 0, LL 0, Ø 0) has been 
reported. The total amount of successful outcome in all teeth collected 
in the present review was very low: 4.9%. This could be due to the 
incomplete data reported, and to a too strictly categories that identified 
the successful outcome. Similar percentage of success were recorded 
for all experimental group 1.5% when BL was used as scaffold, 1.9% 
when PRP was used as scaffold and 0.4% when PRF was used as 
scaffold. It is important to underline that this data could not be 
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significant because in a few number of teeth PRP and PRF has been 
used as scaffold (25 and 10 teeth respectively) respect the BC (151 
teeth).  
Scaffolds are used in regenerative procedures to provide a framework 
through which cells and a vasculature can grow (39). Several report 
have been demonstrated good success with BC scaffold in association 
with MTA (40-43); since it not always possible invoke bleeding in the 
root canals researchers have begun examining other three-dimensional 
scaffold. 
On the basis of current studies more and more case reports and case 
series show favourable outcomes of regenerative endodontic 
procedures, but it is still difficult to predict the outcome and identify 
which steps of the protocol could be potential for optimization of the 
therapy. This could be due to both low level of studies pubblished, 
only 3 RCT were identified in the present study, and to etherogeneus 
methods adopted to judge the outcome of the treatment.   
However, how can a standardized protocol be developed in the 
absence of randomized controlled clinical trials? To address this issue, 
the American Association of Endodontists (AAE) formed a standing 
committee on regenerative endodontics in 2007. This committee has 
developed initiatives for forming an online clinical registry of 
regenerative cases and developing continuing education materials, 
new insurance treatment codes, and a standardized clinical protocol.  
This is a nagging problem of international community of researchs  so 
much so a recent review addresses this problem by focusing on recent 
strategies for developing standardized clinical protocols, and the 
selection of proper outcome measures, as well as reviewing the 
fundamental role of paradigms in designing and interpreting 
regenerative studies (43). 
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